Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in BTAI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$341,573
+$33,148 QoQ
Shares Held
242,251
+5.2% QoQ
Ownership
0.774%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. BTAI ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $341,573 242,251
2026-03-31 $308,425 230,168
2025-12-31 $329,868 206,168
2025-09-30 $320,613 125,240
2025-06-30 $51,008 28,182
2025-03-31 $44,785 22,062
2024-12-31 $116,674 311,965
2024-09-30 $181,806 298,043
2024-06-30 $341,399 266,719
2024-03-31 $1,291,334 457,920
2023-12-31 $1,328,169 450,227
2023-09-30 $1,070,493 423,120
2023-06-30 $2,694,969 404,650
2023-03-31 $7,149,187 383,129
2022-12-31 $8,054,978 374,999
2022-09-30 $4,202,340 355,528
2022-06-30 $4,536,813 343,698
2022-03-31 $6,515,284 311,587
2021-12-31 $6,125,368 301,297
2021-09-30 $9,015,133 297,039
2021-06-30 $8,044,360 276,819
2021-03-31 $10,903,942 252,640
2020-12-31 $10,359,749 224,237
2020-09-30 $8,938,837 206,154
2020-06-30 $8,554,965 161,384
2020-03-31 $3,030,190 135,579